An immunotherapy combination for advanced, highly mutated colorectal cancer (CRC) significantly slowed disease progression versus a single drug, according to a randomized study. Median ...

Caring for someone with metastatic breast cancer can be demanding physically, emotionally, and financially, but there are ...

Fatigue is a very common symptom of metastatic breast cancer, and it can significantly impact quality of life. Here are ways ...

The addition of lenvatinib and pembrolizumab to chemotherapy did not extend OS for certain patients with advanced ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

ONCOMATRYX, a biopharmaceutical company developing novel ADCs against the tumor microenvironment, has successfully raised €25 million, to fund Phase Ib-II clinical trials of OMTX705, a first-in-class ...

An MP diagnosed with breast cancer for a second time wants to "debunk" misconceptions about metastatic cancers. Labour MP for ...

Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...

Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...

Both photodynamic therapy (PDT) and immunotherapy are two of the biggest areas of cancer therapy with the potential to revolutionize healthcare. PDT conveys ...